← Back to Search

Patient activation for Breast Cancer

N/A
Waitlist Available
Led By Kevin C Oeffinger, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial is testing whether a smartphone intervention can help increase breast cancer surveillance rates among women who have been treated for childhood cancer with chest radiation.

Eligible Conditions
  • Breast Cancer
  • Early Detection of Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Women Who Completed a Breast MRI and Mammogram
Other outcome measures
Affect
Barrier Scales (Questionnaire)
Breast Cancer Surveillance Practices - Knowledge of Recommendations (Questionnaire)
+12 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Patient activation (PA)Experimental Treatment2 Interventions
C + patient activation (PA) consisting of (1) smartphone app with HIPAA compliant survivorship care plan that can be viewed, printed, or emailed to their primary care provider; and (2) two-way (interactive) tailored text messages with links to video vignettes discussing the primary barriers to breast MRI and mammography.
Group II: Control (C)Experimental Treatment1 Intervention
Targeted mailed educational materials (C).
Group III: Patient activation + primary care provider activation (PA+PCP)Active Control3 Interventions
C + PA + PCP activation (PA+PCP) with physician materials about breast cancer risk in this population along with national and international guidelines for breast cancer surveillance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient activation
2019
N/A
~320
Control
2011
Completed Phase 4
~15780

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterOTHER
1,934 Previous Clinical Trials
588,496 Total Patients Enrolled
203 Trials studying Breast Cancer
81,137 Patients Enrolled for Breast Cancer
City University of New York, School of Public HealthOTHER
25 Previous Clinical Trials
37,822 Total Patients Enrolled
1 Trials studying Breast Cancer
611 Patients Enrolled for Breast Cancer
Columbia UniversityOTHER
1,432 Previous Clinical Trials
2,460,659 Total Patients Enrolled
29 Trials studying Breast Cancer
23,639 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research currently have an open enrollment period?

"Evidently, clinicaltrials.gov reports that this medical trial is not currently enrolling patients; the first post was made on May 7th 2019 and has been updated as of September 15th 2022. Although no new participants are being recruited for this study, there are over two thousand other trials actively seeking individuals to take part in their research."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
2019. "Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03435380.
~53 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top